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Abstract
We report the clinical experience of radiofrequency ablation followed by radiation therapy
for large primary lung tumors. Two patients with large primary lung tumors were treated with
combined radiofrequency ablation and radiation therapy, and good local control was observed.
Combined radiofrequency ablation and radiation therapy that involves minimally invasive tech-
niques appears to be promising for the treatment of large lung tumors.
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here are limited treatment options for patients 
with non-small cell lung cancer (NSCLC) who 
are not surgical candidates.  Radiofrequency (RF) 
ablation presents a potentially less invasive option 
for these patients.  RF ablation is a relatively new 
modality that has been successfully used for the 
treatment of hepatic tumors [1].  During the past 
few years,  an increasing number of reports have 
described the use of RF ablation for treating malig-
nant lung nodules [2ﾝ4].  The success of this method, 
however,  is limited by tumor size [4].  We treated 2 
patients with large lung tumors with combined RF 
ablation and radiation therapy.
Case Report
　　Two patients with large lung tumors were treated 
with combined RF ablation and radiation therapy. 
Written informed consent was obtained from both 
patients.  Approval of our institutional review board 
was obtained for RF ablation of the lung tumors ; 
however,  the boardｾs approval was not required for 
performing the combined therapy.
　　Case 1.　 The ﬁ rst patient was an 82-year-old 
man who had been previously diagnosed with 
T2N0M0 squamous cell carcinoma of the lung.  Chest 
computed tomography (CT) demonstrated a 6-cm 
tumor in the right lower lobe of the lung (Fig.  1A,  B). 
The patient was not considered a good candidate for 
surgery or chemotherapy because of his advanced age 
and poor pulmonary function.  The tumor appeared 
too large to be treated completely by RF ablation 
alone or radiation therapy alone.  Therefore,  we 
T
We report the clinical experience of radiofrequency ablation followed by radiation therapy for large 
primary lung tumors.  Two patients with large primary lung tumors were treated with combined 
radiofrequency ablation and radiation therapy,  and good local control was observed.  Combined 
radiofrequency ablation and radiation therapy that involves minimally invasive techniques appears 
to be promising for the treatment of large lung tumors.
Key words : radiofrequency ablationｳ  lung cancerｳ  radiation therapy
Acta Med.  Okayama,  2007
Vol.  61,  No.  3,  pp.  177ﾝ180
http ://www.lib.okayama-u.ac.jp/www/acta/
CopyrightⒸ 2007 by Okayama University Medical School.
Case Report
Received October 20, 2006 ; accepted January 10, 2007.
 ＊Corresponding author. Phone : ＋81ﾝ86ﾝ235ﾝ7315 ; Fax : ＋81ﾝ86ﾝ235ﾝ7316
E-mail : t-mukai@okayama3ｴhospｴgo.jp (T. Mukai)
1
Mukai et al.: Radiofrequency ablation followed by radiation therapy for large p
Produced by The Berkeley Electronic Press, 2007
decided to treat the tumor by combining RF ablation 
and external beam radiation therapy.
　　First,  RF ablation was performed under CT guid-
ance (Fig.  1C).  The treatment was performed under 
local anesthesia and conscious sedation that was 
achieved by means of intravenous fentanyl chloride 
infusion.  A cluster internally cooled electrode (Cool-
Tip,  Radionics/ValleyLab,  Boulder,  CO,  USA) was 
placed inside the tumor under CT ﬂ uoroscopic guid-
ance.  Once proper electrode positioning was con-
ﬁ rmed,  we attached the electrode to a 500-kHz 
monopolar radiofrequency generator (Cosman 
Coagulator-1,  Radionics/ValleyLab).  Overlapping 
ablations were performed by repositioning the needle 
in an attempt to ablate the entire tumor.  Pneumo-
thorax developed after RF ablation,  necessitating 
chest drainage and pleurodesis.
　　External beam radiation therapy was performed 2 
months after RF ablation (Fig.  1D).  Radiation 
thera py was performed by using a linear accelerator 
(10 MV) with an anterior-posterior parallel opposed 
pair of portals.  The patient received 50 Gy in 25 
fractions.  The total dose was administered to the 
radiation ﬁ eld that consisted of the primary tumor 
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Fig. 1　　Case 1.  An 82-year-old man who had been previously diagnosed with T2N0M0 squamous cell carcinoma of the lung.
A,  B,  Contrast-enhanced chest CT demonstrated an enhanced 6-cm tumor in the right lower lobe of the lung ; C,  CT ﬂ uoroscopy image 
shows the radiofrequency electrode in the tumor ; D,  Radiation therapy was performed 2 months after RF ablation.  The patient received 
50 Gy in 25 fractions ; E,  F,  CT images obtained 9 months after the completion of the combined therapy do not show any evidence of 
tumor enhancement.  The tumor shrinkage and cavity formation are visible.
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including the movement area by 
respiration.  The ipsilateral hilum 
was not included in the radiation 
ﬁ eld because lymph node metasta-
sis was not detected.  Although 
administration of a total dose of 
60 Gy was initially planned,  radi-
ation therapy was discontinued 
when a total dose of 50 Gy had 
been administered due to granulo-
cytopenia.
　　The CT images obtained 5 
months after the completion of 
the combined therapy showed 
tumor shrinkage (4.5 cm in diame-
ter) without contrast enhancement 
(Fig.  1E,  F).  The CT images 
obtained 14 months after the 
completion of the combined ther-
apy showed no evidence of tumor 
recurrence,  although radiation 
fibrosis was observed.  The 
patient died of acute heart failure 17 months after 
the completion of the combined therapy.
　　Case 2.　 The second patient was a 61-year-old 
man with T2N0M0 adenocarcinoma of the lung.  The 
patient was not considered a good candidate for sur-
gery because of poor cardiac function,  and thus sys-
temic chemotherapy was undertaken.  Although the 
patient showed a dramatic response to chemotherapy 
for about 5 years,  local progression of the tumor 
was subsequently detected.  The CT examination 
revealed a 55-mm tumor in the right upper lobe of 
the lung.
　　At the patientｾs insistence,  the tumor was treated 
twice by RF ablation alone.  However,  the CT and 
magnetic resonance (MR) images obtained 3 months 
after RF ablation showed local tumor progression 
(Fig.  2A).  The tumor appeared too large to be 
treated completely by RF ablation alone. 
Subsequently,  informed consent was obtained from 
the patient for the combined therapy.  During the 
third treatment session,  combined RF ablation and 
radiation therapy was performed.  The CT images 
obtained prior to the treatment showed a 98-mm 
tumor in the right upper lobe of the lung ; however, 
no obvious lymph nodes were observed in the medias-
tinum or hilum.  First,  RF ablation was performed 
under CT guidance by using a single internally cooled 
electrode (Cool-Tip,  Radionics/ValleyLab). 
Overlapping ablations were performed by reposition-
ing the needle in an attempt to ablate the entire 
tumor.  External beam radiation therapy was per-
formed 10 days after RF ablation.  The patient 
received 60 Gy in 30 fractions.  After the completion 
of the combined therapy,  the patient suﬀ ered from 
ileus and was diagnosed with advanced colon cancer.
　　The MR images obtained 4 months after the com-
pletion of the combined therapy showed no evidence 
of tumor recurrence (Fig.  2B).  Six months after the 
combined therapy,  the patient died of colon cancer 
and pneumonia that had developed during chemother-
apy.
Discussion
　　During the past few years,  an increasing number 
of reports have described the use of RF ablation for 
malignant lung nodules.  The success of this method, 
however,  is limited by tumor size.  Akeboshi et al. 
reported 54 lung neoplasms in 31 patients who were 
treated by RF ablation [4].  There was a signiﬁ cant 
diﬀ erence in the rate of complete tumor necrosis 
between the tumors that were 3 cm or less in size 
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Fig. 2　　Case 2.  A 61-year-old man with T2N0M0 adenocarcinoma of the lung.
A,  Contrast-enhanced T1-weighted MR images obtained 3 months after the second RF 
ablation shows an enhanced residual tumor at the periphery (arrow) ; B,  Contrast-
enhanced T1-weighted MR images obtained 4 months after the completion of the com-
bined therapy do not show any evidence of tumor enhancement.
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and tumors that were larger than 3 cm (69ｵ vs.  39
ｵ ; p < 0.05).
　　External beam radiation has been traditionally 
used for patients who are unable to tolerate pulmo-
nary resection.  Morita et al.  compiled the results of 
a study conducted in 10 institutions involving 149 
patients with stage I NSCLC who were considered 
to be medically inoperable [5].  The mean dose of 
radiation administered to these patients was 64.7 Gy. 
The actuarial 3- and 5-year survival rates were 34.2
ｵ and 22.2ｵ,  respectively.  The tumor size was of 
prognostic importance.  When the diameter of the 
primary tumor was 3 cm or less,  the complete 
response rate was 54ｵ,  but it was only 28ｵ in 
patients with tumors that were more than 3 cm in 
diameter.  To treat large tumors that are more than 
3 cm in diameter,  radiation therapy alone might not 
be suﬃ  cient.
　　Tissue heating by RF ablation induces coagulation 
necrosis and cell death,  including destruction of the 
centrally located hypoxic tumor that is typically less 
responsive to chemotherapy and radiation therapy [6]. 
On the other hand,  there are concerns regarding the 
presence of viable tumor cells persisting at the 
periphery because the aerated lung diminishes the 
conduction of RF current and heat.  To counteract 
this principle,  Jain et al.  combined RF ablation with 
radiotherapy in the form of brachytherapy [6]. 
Three patients were treated with combined RF abla-
tion and brachytherapy,  and good local control was 
observed.  We combined external beam radiation 
therapy with RF ablation to provide a more deﬁ nitive 
local therapy.  In our cases,  the lung tumors 
appeared too large to be treated by brachytherapy.
　　In a previous study,  Harkan et al.  had reported 
that in a rat breast tumor model,  an increased rate 
of animal survival was observed when combined RF 
ablation and radiation therapy was used than when 
RF ablation alone or radiation alone was used [7]. 
They suggested that one potential cause of this syn-
ergy might be the increased oxygenation in blood ﬂ ow 
to the tumor,  caused by local hyperthermia induced 
in tissues peripheral to the ablated region.  Increased 
oxygenation has been implicated in the sensitization 
of the tumor to the subsequent radiation therapy. 
The cytoreduction induced by RF ablation could 
decrease the number of tumor viable cells that could 
be subsequently controlled by radiation.  In our ﬁ rst 
patient,  external beam radiation therapy was per-
formed 2 months after RF ablation because the 
patient was being treated for pneumothorax.  This 
interval between RF ablation and radiation therapy 
might not allow the synergy induced by increased 
oxygenation in the tissues at the periphery of the 
ablated region.  The cytoreduction induced by RF 
ablation appears to be the main advantage of the 
combined therapy.  Although there are concerns 
regarding damage to the normal lung tissue present 
in a radiation ﬁ eld,  the degree of radiation ﬁ brosis 
observed in our cases was acceptable.
　　Combined RF ablation and radiation therapy that 
involves minimally invasive techniques appears to be 
promising for the treatment of large lung tumors. 
However,  further basic science and clinical research 
is required to elucidate the relationship between RF 
ablation and radiation therapy and their potential for 
combined therapy for treating lung tumors.
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